Cancer Stock News: BriaCell $BCTX shares positive Phase 3 biomarker data for Bria-IMT in metastatic breast cancer. Patients showing immune response had longer progression-free survival, with no new safety issues. NEWS:
https://globenewswire.com/news-release/2025/1...-2025.html